Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Hematology > MYELOPROLIFERATIVE DISORDERS > Flashcards

MYELOPROLIFERATIVE DISORDERS Flashcards

1
Q

[POLYCYTHAEMIA VERA (PV)]

What is the definition of polycythaemia?

A

: increase in Hb, HCT (red cell mass) and RCC.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

[POLYCYTHAEMIA VERA (PV)]

What is the definition of absolute erythrocytosis?

A

true increase in red cell volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

[POLYCYTHAEMIA VERA (PV)]

What is the definition of relative erythrocytosis?

A

normal red cell volume but decrease in plasma volume e.g. burns, dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

[POLYCYTHAEMIA VERA (PV)] What are the causes of secondary polycythaemia?

A

Due to an appropriate (hypoxic) increase in erythropoietin (e.g. high altitude, lung disease, CVS disease etc.) OR

Due to an inappropriate increase in erythropoietin (e.g. renal cell carcinoma, Wilm’s tumour, Chuvasch polycythaemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

[POLYCYTHAEMIA VERA (PV)]

  • Clonal stem cell disorder leading to excessive proliferation of __________________ progenitor cells
  • Hence, we will expect to see both ________________
  • Over 95% of patients with PV have acquired mutations of the gene ________________ mutation which causes tyrosine kinase to be constantly switched on, leading to cell proliferation.
  • Aka there is increased sensitivity to EPO, with absolute EPO levels being LOW due to -ve feedback
A

erythroid (predominant), myeloid and megakaryocytic

leucocytosis, thrombocytosis and erythrocytosis (predominant finding)

Janus Kinase 2 (JAK2) 🡪 V617F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

[POLYCYTHAEMIA VERA (PV)]

What are the symptoms of PV?

A

Symptoms of hyperviscosity

  • Headache, light-headedness, stroke
  • Visual disturbances
  • Fatigue, dyspnoea

Increased histamine release (due to increased Basophils and Mast cells produced)

  • Aquagenic pruritus (pruritic following warm bath or shower)
  • Peptic ulceration (due to activation of H2 receptor on parietal cells 🡪 abdominal pain)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

[POLYCYTHAEMIA VERA (PV)]

What are the signs of PV?

A

Extramedullary Haematopoiesis

  • Variable splenomegaly due to increased RBC turnover and production
  • Hepatomegaly

Hyperviscosity

  • Plethora (flushing) of the face and deep dusky cyanosis
  • Retinal vein engorgement 🡪 causing transient visual disturbance
  • Injected conjunctiva (due to engorged veins)

Thrombotic Risk

  • Erythromelalgia (red painful extremities): Burning pain in the feet or hands accompanied by erythema, pallor, or cyanosis, in the presence of palpable pulses
  • Thrombosis – DVT, PE, Stroke, AMI

Others

  • Haemorrhage
  • Gout due to increased red cell turnover and overproduction of uric acid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

[POLYCYTHAEMIA VERA (PV)]

What are the investigations performed for PV?

A
  • Increased haemoglobin and haematocrit
  • May be masked by Fe Def Anemia – check Fe and ferritin levels!
  • Thrombocytosis (Platelets are increased in both PV and ET)
  • White cells normal or moderately increased
  • Increased red cell mass and plasma volume
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

[POLYCYTHAEMIA VERA (PV)]

How is PV diagnosed?

A

Raised haematocrit (normal = 40-50%)

Normal Plasma Volume

Mutation in JAK2

If JAK2 negative but other features suggestive:

  • Low serum erythropoietin
  • Splenomegaly clinically or US
  • Red cell mass studies
  • Bone marrow biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

[POLYCYTHAEMIA VERA (PV)]

How is PV managed?

A

Aim to reduce viscosity: Keep HCT <45%

  • Venesections
  • Chemotherapy

Aim to reduce risk of thrombosis

  • Aspirin
  • Keep platelets < 400,000 x 109
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

[POLYCYTHAEMIA VERA (PV)]

What is the prognosis of patients with PV?

A

PV develops into myelofibrosis in 30% of cases and into acute myeloblastic leukaemia in 5% as part of the natural history of the disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

[ESSENTIAL THROMBOCYTHAEMIA (ET)]

  • Essential thrombocythaemia (ET) is a chronic MPN mainly involving megakaryocytic lineage.
  • There is sustained thrombocytosis >__________.
  • The incidence is 1.5 per 100000 and there are 2 peaks: 55 years + minor peak 30 years.
A

600x109/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

[ESSENTIAL THROMBOCYTHAEMIA (ET)]

What are the clinical features of ET?

A

Thrombosis: arterial or venous

  • CVA, gangrene, TIA
  • DVT or PE

Bleeding: mucous membrane and cutaneous (platelets count raised but may not be effective)

Findings a/w increased cellular proliferation

  • +/- Symptoms of hyperviscosity: Headaches, dizziness, visual disturbances
  • +/- Splenomegaly (usually modest)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

[ESSENTIAL THROMBOCYTHAEMIA (ET)]

What are the investigations performed for ET?

A

No gold standard for diagnosis

Platelet count consistently above 600x109/L

Megakaryocyte abnormalities & clustering in BM

JAK 2 V617F mutation (50%)

Splenomegaly – slight, may even be non-palpable

Spontaneous erythroid/ megakaryocytic colonies independent of growth factors

Normal ESR and CRP – no signs of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

[ESSENTIAL THROMBOCYTHAEMIA (ET)]

What is the management of ET?

A

Aspirin to prevent thrombosis
- High risk of thrombosis:
age>60, thrombosis/ haemorrhagic/ ischemic symptoms, platelets >1000x109

Hydroxycarbamide (aka Hydroxyurea)

  • Antimetabolite
  • Suppresses the platelet count
  • Myelosuppressive: can also suppress white blood cell count and haemoglobin 🡪 Possibly mildly leukaemogenic
  • Also used in Sickle Cell Disease to increase HbF
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

[MYELOFIBROSIS]
Myelofibrosis is a clonal myeloproliferative disease with proliferation mainly of _________& __________, associated with reactive _____________& _________

Primary myelofibrosis has an incidence of 0.5-1.5/100000 and peaks in the 7th decade.

A

megakaryocytes & granulocytic cells

bone marrow fibrosis & extramedullary haematopoiesis.

17
Q

[MYELOFIBROSIS]

What are the clinical features of myelofibrosis?

A

Clinical Features

  • Hypermetabolic state:
  • Weight loss
  • Fatigue and dyspnoea
  • Night sweats
  • Thought to be due to increased inflamm markers (IL6) released due to abnormal blood cells

Changes in other cell lines:

  • Anaemia
  • Thrombocytopenia OR Thrombocytosis
  • Leucocytosis OR Leukocytopenia

Splenomegaly: may be massive

Hepatomegaly

18
Q

[MYELOFIBROSIS]

What are the stages of myelofibrosis?

A

1) Prefibrotic Stage
- Presence of Leucocytosis and Thrombocytosis
- Neutrophils are left shifted + Abnormal large platelets due to fibrotic BM pushing out the immature cells
- There may be presence of immature nucleated RBC in PBF
- Blood changes mild, but may be confused with ET
- Marrow hypercellular

Fibrotic Stage

  • Fibrosis occurs due to the PDGF released by abnormal platelets that stimulate fibroblasts in BM
  • Splenomegaly & blood changes (very hard to predict the ultimate changes in WCC and Platelet count. However, there is definitely anemia)
  • Anemia
  • Dry tap (difficult to aspirate bone marrow aspirate) – hypocellular and fibrotic
  • Prominent collagen fibrosis
  • Osteosclerosis (later)
19
Q

[MYELOFIBROSIS]

What are the investigations performed in patients with myelofibrosis?

A

Peripheral blood film

  • Leucoerythroblastic picture (immature RBC and WBC normally only found in the bone marrow.)
  • Tear Drop Poikilocytes (poikilocytes = abnormally shaped RBC) 🡪 also seen in Beta Thalassemia major

Bone marrow

  • Dry tap
  • Fibrotic bone marrow (on bone marrow trephine)

Cytogenetics:

  • Absent Philadelphia chromosome (differentiates from CML)
  • JAK2 mutation in 50%

FBC: High platelet count, but thrombocytopenia in later stages

20
Q

[MYELOFIBROSIS]

What is the prognosis of myelofibrosis?

A

Median survival 3-5 years but very variable

Bad prognostic signs:

  • Severe anaemia <10g/dL
  • Thrombocytopenia <100x109/l
  • Massive splenomegaly

Hematology (19 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions